Locally Advanced Stage III or IV Thymic Cancer Clinical Trial
Official title:
A Prospective, Phase II Trial of Induction Chemotherapy With Docetaxel/Cisplatin for Masaoka Stage III/IV Thymic Epithelial Tumors
We try to evaluate whether neoadjuvant docetaxel plus cisplatin can increase the complete resection rate in advanced thymic carcinoma.
n/a
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment